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Claudins are major components of tight junctions and contribute to the epithelial-barrier function by restricting free
diffusion of solutes through the paracellular pathway. We have mapped a new locus for recessive renal magnesium loss
on chromosome 1p34.2 and have identiﬁed mutations in CLDN19, a member of the claudin multigene family, in patients
affected by hypomagnesemia, renal failure, and severe ocular abnormalities. CLDN19 encodes the tight-junction protein
claudin-19, and we demonstrate high expression of CLDN19 in renal tubules and the retina. The identiﬁed mutations
interfere severely with either cell-membrane trafﬁcking or the assembly of the claudin-19 protein. The identiﬁcation of
CLDN19 mutations in patients with chronic renal failure and severe visual impairment supports the fundamental role
of claudin-19 for normal renal tubular function and undisturbed organization and development of the retina.
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Tight junctions constitute cell-cell contacts by forming cir-
cumferential belts around epithelial or endothelial cells
in many organs. These dynamic microstructures are in-
volved in several major cellular functions1: ﬁrst, they con-
struct a “fence” that generates cell polarity by separating
apical and basolateral cell domains; second, they form traf-
ﬁcking and signaling platforms involved in the regulation
of growth, proliferation, and differentiation of cells; third,
they serve as a regulatory barrier (“gate”) that separates
ﬂuid compartments of different compositions (e.g. in the
kidney, intestine, and brain). The gate properties of tight
junctions are derived primarily from claudin proteins that
form porelike structures that participate in the regulation
of paracellular movements of ions such as magnesium.
Claudins are thought to form heterodimers or -oligomers,
and barrier properties of tight junctions seem to depend
on the expression proﬁles of participating claudins.2,3 In
the kidney, claudins confer ion selectivity to the paracel-
lular pathway that, in particular, is important for ion reab-
sorption in tubular epithelia.4,5
Mutations in CLDN16 (which encodes claudin-16) have
been identiﬁed in familial hypomagnesemia with hyper-
calciuria and nephrocalcinosis (FHHNC [MIM *248250]),
a recessive renal disorder of paracellular magnesium and
calcium reabsorption in the thick ascending limbofHenle’s
loop (TAL).6–8 In rare cases, CLDN16 mutations lead to tran-
sient hypercalciuria with nephrocalcinosis without signif-
icant disturbance of magnesium reabsorption.9
We have clinically characterized one Swiss and eight
Spanish/Hispanic families affected with severe hypomag-
nesemia due to renal wasting, nephrocalcinosis, and pro-
gressive renal failure but did not have any mutations in
CLDN16 (table 1). Detailed clinical data about families
F48–F51 and F76 were reported elsewhere.10,11 The renal
phenotype was virtually undistinguishable from that of
patients with FHHNC with proven CLDN16 mutations.
However, the affected individuals in these families also
have severe visual impairment, characterized by macular
colobomata, signiﬁcant myopia, and horizontal nystag-
mus. With the assumption of the involvement of a second
locus in the non-CLDN16 hypomagnesemic patients, we
performed a genome scan for shared homozygous regions
in these families of known and suspected consanguinity.
Informed consent was obtained from all participating in-
dividuals. We genotyped ﬁve members of the Swiss fam-
ily and all Spanish/Hispanic patients, using a 50,000-SNP
array (Affymetrix GeneChip Human Mapping 50K Array
Xba240). Genomewide linkage analysis was performed,
Figure 1. Mapping of a new gene locus for recessive renal hypomagnesemia on 1p34.2. A, Application of a reduced subset of 7,802 informative autosomal SNPs. The highest (by
far) HLOD score was identiﬁed on chromosome 1p34.2, with a peak value of 6.4. Physical positions of the SNP markers are depicted on the abscissa. B, A critical interval of !2
Mb, revealed by comparison of the patients’ haplotypes. The position of the candidate gene CLDN19 and the ﬂanking SNP markers (highlighted in yellow) are depicted. Homozygous
genotypes are indicated by “1” or “2,” heterozygous genotypes are indicated by a times sign (#), and SNPs without a genotype are indicated by a minus sign (). The two
different haplotypes are drawn in green (for the Swiss sample) or blue (for the Spanish/Hispanic samples). Boxed haplotype segments are identical by descent.
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Figure 2. A, Pedigree of the extended Swiss family with two affected siblings (blackened symbols). Wild-type and mutant sequences
for the CLDN19 Q57E mutation analysis are marked by a minus sign () and a plus sign (), respectively. B, Pedigrees of eight Spanish/
Hispanic families with results of the CLDN19 G20D mutation. In one family (F52), CLDN19-mutation analysis was negative. C, Turkish
family with two affected individuals, with results of the CLDN19 L90P mutation analysis. D, CLDN19 sequence analysis. Chromatograms
of homozygous mutations (top), compared with heterozygous carriers (middle) and wild-type sequences (bottom).
with the assumption of heterogeneity and second-degree
cousin marriages for the parents of the Spanish/Hispanic
families. A critical region on chromosome 1p34.2, with a
highly signiﬁcant heterogeneity LOD score (HLOD) of 6.4,
was identiﬁed using Genehunter-Modscore12,13 (ﬁg. 1A).
On the basis of the haplotype data from patients with
extended homozygosity, this interval is delimited by SNP
markers rs3845572 and rs2367190 and comprises ∼2 Mb,
with CLDN19 as the most promising positional candidate
(ﬁg. 1B) (Ensembl).CLDN19was still in the critical interval
of ∼740 kb, even when a less precise deﬁnition was used
and additional patients with shorter homozygous seg-
ments in that region were considered. Only one Spanish/
Hispanic patient (F52) did not show a homozygous seg-
ment in this interval.
CLDN19 encodes for claudin-19, a recently described
member of the claudin multigene family. Claudin-19 is
expressed in few organs, and the highest levels are found
in the kidney and the eye (UniGene proﬁle). By sequence
analysis of the coding region and the adjacent intron/
exon boundaries, we identiﬁed two different homozygous
missense mutations, a Spanish/Hispanicmutation (G20D)
located in the ﬁrst transmembrane domain that was iden-
tiﬁed in all Spanish/Hispanic patients except F52, and a
Swiss mutation (Q57E) located in the ﬁrst extracellular
loop of claudin-19 (ﬁgs. 2A, 2B, and 3) (primer sequences
are available on request). The G20 and Q57 residues of
the claudin-19 protein are highly conserved throughout
evolution, and both mutations replace a neutral with a
negatively charged amino acid. SIFT (sorting intolerant
from tolerant) analysis supports the pathogenicity of both
mutations. In addition, the twomutations cosegregatewith
the disease phenotype and were not found in 196 ethnic-
ally matched control chromosomes for the Spanish/His-
panic mutation or 150 Swiss individuals (300 chromo-
somes) for the Swiss mutation (number of controls allows
detection of a 1% polymorphism with a power of 0.8).
Obviously, a recent founder effect is responsible for the
concordance of the mutation in all Spanish/Hispanic pa-
tients, since it is embedded into the same haplotype back-
ground that extends over 1450 kb (ﬁg. 1B).
Functional analysis of G20D and Q57E claudin-19 was
performed by heterologous expression of the mutants in
Madin-Darby canine kidney (MDCK) cells. For immuno-
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Figure 3. Predicted model of claudin-19, with four transmembrane domains, two extracellular loops, and intracellular termini. The
ﬁrst loop is characterized by the claudin-speciﬁc amino acid motif W-GLW-C-C. The Spanish/Hispanic mutation G20D is localized in the
ﬁrst transmembrane domain, the Swiss mutation Q57E affects a residue located between the two cysteines of the W-GLW-C-C motif,
and the Turkish mutation L90P resides in the second transmembrane domain.
Table 1. Phenotypic Characteristics of the Patient Cohort
Characteristic
Findings for Patient
F76.V-4a F76.V-1 F75.II-1 F48.II-1 F68.II-1 F49.II-3 F51-II-1 F50.II-1 F67.II-1 F52.II-2 F90.IV-2 F90.IV-3
Ethnic Origin Swiss Swiss Spanish Spanish Hispanic Spanish Spanish Spanish Hispanic Spanish Turkish Turkish
Sex M F M M F F M M M M F M
Age (in years) at symptoms
onset 0.8 6.0 3.0 3.6 0.5 7.7 0.2 0.8 0.1 0.8 0.9 0.2
Present age (in years) 39 36 49 26 3.0 18 10 21 14 10 2.5 1.0
Renal phenotypeb:
Nephrolithiasis Yes Yes Yes No No No No No No Yes No Yes
Urinary tract infections Yes Yes No No Yes Yes Yes No No Yes Yes Yes
Actual renal functionc TPL TPL CRF CRF Normal CRF CRF CRF TPL TPL Normal Normal
Ocular phenotype:
Macular colobomata Yes Yes No Yes No No No Yes Unknown No Yes Unknown
Nystagmus Yes Yes Yes Yes Yes Yes Yes Yes Unknown Yes Yes Yes
Myopia Yes Yes Yes Yes Yes Yes Nod Yes Yes No Yes Yes
a Deceased.
b All patients are or were affected with hypomagnesemia, hypercalciuria, and nephrocalcinosis.
c TPL indicates that the patient underwent kidney transplantation; CRF indicates that the patient experienced chronic renal failure.
d Unconﬁrmed.
detection, a V5-epitope sequence was added to the car-
boxy terminus of the claudin-19 constructs. These were
then transiently expressed in MDCK cells, were stained
with a mouse monoclonal anti-V5 antibody (Invitrogen)
and a Cy2-coupled goat–anti-mouse polyclonal antibody
(Jackson Immuno Research), and were visualized by laser
scanning microscopy. Expression analysis revealed peri-
nuclear retention of the G20D mutant, whereas wild-type
claudin-19 is targeted to the cell membrane, which points
to a trafﬁcking defect (ﬁg. 4). This trafﬁcking defect of the
mutant is explained by a disturbance of the signal-peptide
sequence, corresponding to the ﬁrst 20 aa of the claudin-
19 protein, as predicted by in silico analysis (SignalP 3.0).
The Q57E mutant, however, inserts correctly into the cell
membrane. This missense mutation is located in the re-
gion of the W-GLW-C-C signature sequence that charac-
terizes all members of the claudin family3 (ﬁg. 3). A 3D
model of the ﬁrst 115 aa of claudin-19 was constructed
using ROSETTA de novo methods, with use of a structure
library of protein fragments.14 Quality of the model was
checked by WHATCHECK15 and Ramachandran plot anal-
ysis.16 The ﬁnal model was energetically stable and had
the features characteristic of transmembrane proteins (ﬁg.
5A). Since the ﬁrst extracellular loop of claudins is thought
to bridge the paracellular space and claudin-5 has been
said to form homodimers,17 we subsequently tested, by ap-
plying the PATCHDOCK software,18 whether claudin-19
can form a homodimer and whether Q57 has any role in
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Figure 4. Functional analysis of the CLDN19 mutations. Analysis of the subcellular localization of transiently expressed claudin-19 in
MDCK cells demonstrates correct insertion of the wild-type (WT) claudin-19 protein (upper panels) and the Q57E mutant (lower panels)
into the cell membrane. The G20D mutant, however, is retained inside the cell (middle panels). Immunoﬂuorescence images, the
corresponding differential interference contrast images (DIC), and overlays are depicted.
this complex formation. Of the best 10 solutions obtained,
8 showed involvement of the ﬁrst extracellular loop in the
dimer formation, with Q57 of the ﬁrst molecule interact-
ing with Q61 and Q63 of the second molecule (ﬁg. 5B).
This computational model cannot predict whether the
claudin-19 dimer is located in one cell or in opposing cells
bridging the intercellular space; however, it is well known
that members of the claudin family form homo- and het-
erodimers, both interacting laterally and bridging the in-
tercellular space with their extracellular domains.3,19Dock-
ing calculations were repeated after in silico introduction
of the mutation Q57E in the monomeric model. The di-
mer formation was disrupted with the mutant protein,
which is possibly due to strong electrostatic repulsion
from opposing E residues (ﬁg. 5C).
Subsequently, we identiﬁed another consanguineous
family with two children with FHHNC and severe ocular
involvement (family F90 [table 1 and ﬁg. 2C]). This family
is of Turkish origin. Direct sequencing ofCLDN19 revealed
a homozygous L90P mutation in both affected siblings
and was detected at a heterozygous state in the obligate
carriers (ﬁg. 2C and 2D). The possibility of a polymor-
phism was ruled out by testing 220 Turkish control chro-
mosomes. Moreover, SIFT and PolyPhen analyses (score
2.43) indicate pathogenicity of this mutation, and L90 is
highly conserved among claudin genes across all species.
L90 is located in the second transmembrane domain, and
the replacement by a proline disrupts the a-helices, as
predicted by the GOR IV secondary structure–prediction
method. This might be explained by the rigid structure of
the proline residue, where the side chain is covalently
bound to its amino-terminal end. Together with the two
mutation described above, these data clearly indicate that
the pathogenesis of FHHNC with severe ocular abnormal-
ities in humans is explained by mutations in CLDN19.
A recently generated Cldn19 knockout mouse model
demonstrates disorganized tight junctions in the Schwann
cells of the peripheral nervous system, and homozygous
animals show abnormal behavior and peripheral neurop-
athy.20 Visual impairment, electrolyte imbalances, and renal
Figure 5. Three-dimensional structural models of claudin-19. A,
The ﬁrst 115 aa of claudin-19 are shown as a ribbon diagram in
a gradient of rainbow colors, with the N terminus depicted in blue.
The G20D mutation is located in the ﬁrst transmembrane region
that is buried in the membrane. The strong change in the charge
pattern by the replacement of glycine with aspartic acid presum-
ably inﬂuences intramolecular interactions that will alter the signal
sequence. The Q57E mutation is located in the ﬁrst extracellular
loop and is likely to affect electrostatic interactions that result in
altered protein-protein interactions. The L90P mutation is located
in the second transmembrane domain. B, Potential model of clau-
din-19 homodimer formation. A representative docking solution—
which shows the involvement of the ﬁrst extracellular loop in the
dimer formation with Q57 of the ﬁrst molecule interacting with
Q61 and Q63 of the second molecule—is depicted. The two clau-
din-19 molecules are colored in red and blue. The claudin-19 homo-
dimer seems to be stabilized by interaction of Q57 of one molecule
with Q63 of the partner molecule. C, Effect of the Q57E mutation
on claudin-19 homodimer formation. Docking calculations were
repeated after performing in silico mutation of Q57E in the mo-
nomeric model. The dimer formation was disrupted with the mutant
protein, possibly because of strong electrostatic repulsion from
opposing E residues.
Figure 6. Localization of claudin-19 and claudin-16 in mouse
kidney. A–D, In situ hybridization analysis of kidney sections,
which demonstrates highly similar expression patterns of Cldn19
(A and C) and Cldn16 (B and D) in the renal tubules. Scale bars
represent 500 mm in panels A and B and represent 50 mm in panels
C and D. E and F, Negative controls, with Cldn19 (E) and Cldn16
(F) sense probes, which demonstrate the speciﬁcity of the anti-
sense probes. G, RT-PCR analysis of microdissected nephron seg-
ments, which revealed a similar expression pattern for both genes
in the medullary (mTAL) and cortical (cTAL) TAL and in the distal
convoluted tubules (DCT). Marker p 100-bp ladder; Glom p glo-
meruli with (Glom) and without (Glom) blood vessels; PCTp
proximal convoluted tubule; CT/CCDp connecting tubule/cortical
collecting duct; OMCDp outer medullary collecting duct. Negative
and positive control experiments were performed using yeast tRNA/
H2O and kidney RNA, respectively. Obtained PCR products were of
expected size (176 bp for Cldn16; 198 bp for Cldn19). In parallel
with Cldn19 and Cldn16 ampliﬁcation, a set of marker genes was
ampliﬁed (SLC12A1, SLC12A3, AQP1, AQP4, PTHR1, and SLC5A2) as
controls for segment speciﬁcity of the preparation (data not shown).
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Figure 7. Immunoﬂuorescence analysis of claudin-19 and claudin-16 in mouse kidney. A and B, Series kidney sections showing similar
apical staining patterns of claudin-19 and claudin-16 in the TAL and distal tubules. Scale bars represent 25 mm. D and E, Higher
magniﬁcation, which demonstrates protein expression at cell-cell contacts (nuclear staining in blue). Scale bars represent 15 mm. C and
F, Negative control with omission of the primary anti–claudin-19 and anti–claudin-16-antibodies (C) and nuclear staining of the same
section (F).
abnormalities are not reported in that work.20 This might
be because these parameters have not been studied. It is
also possible that phenotypic disparities actually exist be-
tween the human and the murine model, which could be
explained by the fact that different members of the large
claudin family seem to be able to compensate for speciﬁc
claudin defects to a variable extent, dependent on the spe-
cies and the speciﬁc genetic background of the model.
However, previous studies of mice demonstrated a strong
expression of claudin-19 in the distal tubules of the kid-
ney cortex,21 which supports a functional role of claudin-
19 for paracellular electrolyte-transport mechanisms. We
therefore studied the expression of claudin-19 in the kid-
ney in more detail. In situ hybridization analysis was per-
formed using probes that recognize Cldn16 (GenBank ac-
cession number NM_053241 [nucleotides 154–1074]) and
Cldn19 (GenBank accession number BC115827 [nucleo-
tides 63–908]). These experiments revealed a highly sim-
ilar expression pattern of claudin-19 and -16 mRNAs in
mouse cortical kidney tubules (ﬁg. 6A and 6B). Highermag-
niﬁcation of series kidney sections suggests a colocaliza-
tion of both claudins (ﬁg. 6C–6F). To identify the nephron
segments expressing Cldn19, we performed RT-PCR anal-
ysis in microdissected mouse nephron segments (primer
sequences are available on request). Cldn19 is expressed in
exactly the same nephron segments as is Cldn16—namely,
the medullary and cortical TAL, with a lower level of ex-
pression in the distal convoluted tubule (ﬁg. 6G). These
results were conﬁrmed by immunohistochemistry of series
kidney sections with use of polyclonal rabbit anti–claudin-
19 (as described by Lee et al.21) and anti–claudin-16(Zymed)
antibodies at a dilution of 1:200. Anti-rabbit Cy3 (Rock-
land) was used as secondary antibody, at a dilution of 1:
1,600. Bisbenzimide H33258 was used for nuclear staining
(Serva). Consistent with the results of RT-PCR analysis, im-
munohistochemistry revealed a marked apical and slighter
basolateral expression of both claudins in the TAL anddistal
tubules (ﬁg. 7A and 7B). Negative controls were performed
by omission of the primary antibodies (ﬁg. 7C and 7F). At
highermagniﬁcation, the expression of both proteins could
be detected at cell-cell contacts (ﬁg. 7D and 7E). Thus, it
seems possible that both claudins interact at the tight-junc-
tion barrier of the renal tubules involved in paracellular
magnesium and calcium reabsorption.
Immunohistochemistry was subsequently performed on
ocular sections of zebraﬁsh (claudin-19 antibody dilution
1:100). In the eye, claudin-19 is expressed speciﬁcally in
the retina, with a strong expression in the retinal pigment
epithelium (RPE). Additional claudin-19 staining was ob-
served in the inner plexiform layer (IPL) and the inner
nuclear layer (INL) (ﬁg. 8). Negative controls consisted of
omission of the primary antibody and the evaluation of
autoﬂuorescence (data not shown). Different claudins are
known to be expressed during ocular development at the
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Figure 8. Localization of claudin-19 in zebraﬁsh retina. A, Bright
ﬁeld image of a section of a larval retina at 5 d post fertilization.
Scale bar represents 50 mm. GCL p ganglion-cell layer; INL p
inner nuclear layer. B, Punctate staining of claudin-19, detected
in the RPE, including the interdigitating microvilli. The inner nu-
clear and inner synaptic layers show less staining. C, Close-up view
of claudin-19 staining in the outer retina.
tight junctions of the RPE—for example, claudins-1, -2, -5,
and -12—and proper tight-junction formation is required
for apical cell polarity and an intact retinal transfusion
barrier.22 As a consequence, loss of tight-junction forma-
tion can result in the mistargeting of factors that inﬂuence
retinal cell division.22 To our knowledge, the present study
demonstrates for the ﬁrst time that claudin-19 is an impor-
tant component of RPE tight junctions and that patients
affected byCLDN19mutations present with amarkedmis-
development of the optic disc, which is associated with
near blindness and the manifestation of a horizontal nys-
tagmus. The eye phenotypes in patients withCLDN19mu-
tations reported here are much more severe than phe-
notypes reported elsewhere for patients with FHHNC.7 For
a long time, ocular involvement with an FHHNC pheno-
type has been observed with much higher frequency in
Spanish patients than in patients from other parts of the
world (reviewed by Benigno et al.23). We have now pro-
vided evidence that genetic heterogeneity is responsible
for this phenotypic difference and that mutations in
CLDN19 are the causative defect in this subset of patients
(i.e., those with FHHNC and severe ocular involvement).
The identiﬁcation of CLDN19 mutations in patients with
hypomagnesemia, chronic renal failure, and severe visual
impairment supports the fundamental role of claudin-19
for magnesium homeostasis, normal tubular structures in
the kidney, and undisturbed organization and develop-
ment of the retina.
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